Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease

Beat Künzli(Beth Israel Deaconess Medical Center), Simon C. Robson(Beth Israel Deaconess Medical Center), Irfan Halaceli, Markus W. Büchler(Heidelberg University), Thomas Giese(Heidelberg University), Eva Csizmadia(Beth Israel Deaconess Medical Center), Helmut Frieß(TUM Klinikum), Pascal O. Berberat(Technical University of Munich), Colin Baker(University College London Hospitals NHS Foundation Trust), Elżbieta Kaczmarek(Poznan University of Medical Sciences)
American Journal of Physiology-Gastrointestinal and Liver Physiology
August 19, 2006
10.1152/ajpgi.00259.2006
Cited by 160

Related Papers

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer
|Surgery|2009|1.5k